Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anavex Life Sciences

9.36
+0.05000.54%
Post-market: 9.540.1800+1.92%17:33 EDT
Volume:526.78K
Turnover:4.96M
Market Cap:796.20M
PE:-16.94
High:9.59
Open:9.44
Low:9.23
Close:9.31
Loading ...

What To Expect in the Markets This Week

Investopedia
·
22 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
19 Dec 2024

Anavex announces upcoming presentation of data from ATTENTION-AD study

TIPRANKS
·
09 Dec 2024

Anavex Life Sciences Down Over 13%, On Track for Largest Percent Decrease Since January -- Data Talk

Dow Jones
·
06 Dec 2024

Anavex Life Sciences Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
27 Nov 2024

Buy Recommendation for Anavex Life Sciences: Promising Alzheimer’s Treatment and Expanding Clinical Pipeline

TIPRANKS
·
27 Nov 2024

Anavex Submits Marketing Authorization Application to EU Regulator for Blarcamesine to Treat Alzheimer's; Shares Jump Pre-Bell

MT Newswires Live
·
26 Nov 2024

Anavex gains after seeking EU marketing nod for Alzheimer’s drug

seekingalpha
·
26 Nov 2024

Anavex announces submission of blarcamesine MAA to EMA

TIPRANKS
·
26 Nov 2024

Anavex Life Sciences Announces Submission of Blarcamesine Maa for Treatment of Alzheimer’s Disease to Ema

THOMSON REUTERS
·
26 Nov 2024

D. Boral says Anavex Alzheimer’s approach superior to Cassava

TIPRANKS
·
25 Nov 2024

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
25 Nov 2024

BRIEF-Anavex Life Sciences Announces Acceptance Of Peer-Reviewed Manuscript

Reuters
·
25 Nov 2024

Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase Iib/Iii Data in a Reference Alzheimer’s Disease Journal

THOMSON REUTERS
·
25 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
21 Nov 2024

Anavex Life Sciences Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Nov 2024

Anavex Life Sciences: Buy Rating Driven by Promising Blarcamesine Developments and Market Expansion

TIPRANKS
·
04 Nov 2024